Currently, there are 365.24M common shares owned by the public and among those 357.55M shares have been available to trade.
The company’s stock has a 5-day price change of 5.01% and -12.51% over the past three months. BHC shares are trading -5.86% year to date (YTD), with the 12-month market performance down to -10.44% lower. It has a 12-month low price of $6.05 and touched a high of $11.46 over the same period. BHC has an average intraday trading volume of 2.75 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 8.09%, 11.00%, and -3.60% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Bausch Health Companies Inc (NYSE: BHC) shares accounts for 77.93% of the company’s 365.24M shares outstanding.
It has a market capitalization of $2.77B and a beta (3y monthly) value of 0.77. The earnings-per-share (ttm) stands at -$1.24. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.55% over the week and 3.36% over the month.
Earnings per share for the fiscal year are expected to increase by 3.63%, and 16.38% over the next financial year. EPS should shrink at an annualized rate of 2.60% over the next five years, compared to 32.76% over the past 5-year period.
Looking at the support for the BHC, a number of firms have released research notes about the stock. Raymond James stated their Mkt Perform rating for the stock in a research note on July 10, 2024, with the firm’s price target at $8. Jefferies coverage for the Bausch Health Companies Inc (BHC) stock in a research note released on September 20, 2023 offered a Buy rating with a price target of $16. RBC Capital Mkts on their part issued Sector Perform rating on July 29, 2022.
